Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases.
about
Texaphyrins and water-soluble zinc(II) ionophores: development, mechanism of anticancer activity, and synergistic effectsWhole brain radiotherapy with radiosensitizer for brain metastasesThe role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cellsMotexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.Motexafin gadolinium (Gd-Tex) selectively induces apoptosis in HIV-1 infected CD4+ T helper cells.Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignanciesMotexafin gadolinium: a possible new radiosensitiser.Monte Carlo study of radiation dose enhancement by gadolinium in megavoltage and high dose rate radiotherapy.Stereotactic radiosurgery: adjacent tissue injury and response after high-dose single fraction radiation. Part II: Strategies for therapeutic enhancement, brain injury mitigation, and brain injury repair.Motexafin gadolinium: a novel radiosensitizer for brain tumors.Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer.Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study.The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trial.HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy.Anticancer activity of metal complexes: involvement of redox processes.Motexafin gadolinium: a promising radiation sensitizer in brain metastasis.Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?Population pharmacokinetics of motexafin gadolinium in adults with brain metastases or glioblastoma multiforme.Brain metastases research 1990-2010: pattern of citation and systematic review of highly cited articles.The impact of mid-treatment MRI on defining boost volumes in the radiation treatment of glioblastoma multiforme.
P2860
Q30858160-668D351D-E361-4C2B-BB89-8B7021322A77Q33397865-EACF8714-152E-47F3-96C2-7A64CDB4DD91Q33599167-2312948B-00B7-42D6-B942-121DB8CC4454Q33699108-9312350C-8553-4083-A5CE-A1D6048E8673Q33975357-93F6BF8B-0172-4B82-9C82-65E956BAE74FQ34013033-1224886F-CAA6-4200-A679-49E935E50E68Q34570658-177C5023-49AF-48F3-9E1C-E19EB134AD52Q35164769-AF54A1C0-434B-4148-89B5-0B831C4B3310Q35294967-66DA5313-E089-4336-9165-2A56BA74A862Q36802285-1F4FAEC5-D8E0-4166-B68B-98ABBFC62EBEQ36842747-27789CE4-1385-4314-B63C-072D7798B518Q36920440-0594DDA3-5F5F-422B-B6D6-031D897A2FC0Q37152041-EAEBF9DE-F858-4188-9D99-F70BA2B57FF8Q37390535-7F5D7F9A-EB50-482C-9D06-552E287B317DQ37662142-909B4685-7D85-439C-BCD8-6E20F0881C16Q37833099-021F89A4-B912-454D-92A6-B2BDAB5C47BEQ38014582-BDCCA920-25F3-4BAC-8CD9-FD9E9A4B76AAQ39380445-AA534F5C-1D38-4544-BD1F-0B1A43B61FB8Q42647577-FF4024CA-38D1-49F9-9B15-8C2B2B4AD36CQ51193862-6142FD89-C0C1-4BA4-925A-472E394CE137Q55472152-A17791BA-CFED-4D23-94A4-F7218208CBCD
P2860
Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Multicenter phase Ib/II trial ...... atients with brain metastases.
@ast
Multicenter phase Ib/II trial ...... atients with brain metastases.
@en
type
label
Multicenter phase Ib/II trial ...... atients with brain metastases.
@ast
Multicenter phase Ib/II trial ...... atients with brain metastases.
@en
prefLabel
Multicenter phase Ib/II trial ...... atients with brain metastases.
@ast
Multicenter phase Ib/II trial ...... atients with brain metastases.
@en
P2093
P1476
Multicenter phase Ib/II trial ...... atients with brain metastases.
@en
P2093
C D Koprowski
M F Renschler
R A Miller
R B Tishler
R Timmerman
P304
P356
10.1200/JCO.2001.19.7.2074
P407
P577
2001-04-01T00:00:00Z